Mark Dunphy, DO

Mark Dunphy, DO

My expertise as a physician is in the use of radiopharmaceuticals for the diagnosis, evaluation, and treatment of disease. I serve patients through clinical work and research. My clinical role is the providing of state-of-the-art care in nuclear medicine, including positron emission tomography, radioiodide therapy, and radioimmunotherapy. In research, targeted imaging for targeted therapy is my general subject of study; imaging the pharmacokinetics and biomolecular pharmacodynamics of targeted anti-tumor agents promises to revolutionize patient selection, dose selection, and tumor monitoring, serving as tools to tailor cancer care to the individual.

The Society of Nuclear Medicine gave me the 2006 Alavi-Mandell Award for my published research on positron emission tomography and cardiovascular disease.

Location
Phone
212-639-8131
Clinical Expertise

Nuclear Oncology; Nuclear Cardiology; Positron Emission Tomography; Radioiodide Therapy

Languages Spoken
English
Education

DO, Michigan State University College of Osteopathic Medicine

Residencies

Memorial Sloan Kettering Cancer Center

Fellowships

Memorial Sloan Kettering Cancer Center

Board Certifications

Nuclear Medicine

Publications by Mark Dunphy
Visit PubMed for full listing of Mark Dunphy journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.